3 ms·
The FDA has announced that boosters to address novel strains will undergo a rapid review process. Full details of what that will involve are expected in 2 to 3
by tssva 6y ago
The FDA has announced that boosters to address novel strains will undergo a rapid review process. Full details of what that will involve are expected in 2 to 3 weeks.